SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-09-059789
Filing Date
2009-10-21
Accepted
2009-10-21 15:45:58
Documents
1
Period of Report
2009-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A a09-31877_18ka.htm 8-K/A 57805
  Complete submission text file 0001104659-09-059789.txt   59915
Mailing Address 119 FOURTH AVENUE NEEDHAM MA 02494
Business Address 119 FOURTH AVENUE NEEDHAM MA 02494 781 433 0771
CURAGEN CORP (Filer) CIK: 0001030653 (see all company filings)

IRS No.: 061331400 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-23223 | Film No.: 091130141
SIC: 8731 Services-Commercial Physical & Biological Research